Cumberland Pharmaceuticals (CPIX) Reports Q4 Loss of $0.05/sh

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.05). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $8.07 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Goldman: 'Our top picks include XYZ, KLAR, AFRM, and CHYM'
• Abbvie (ABBV) PT Raised to $261 at Guggenheim
• Truist Securities Upgrades Solstice Advanced Materials Inc. (SOLS) to Buy, Buying Oppy